Evaluation of Quality of Care - Shared-Care Programme, HA (QoC SCP)
Diabetes mellitus (DM) and hypertension (HT) are major causes of morbidity and among the top 10 causes of deaths in Hong Kong in 2008 (Department of Health 2009). The Hospital Authority (HA) has initiated service improvement through introducing the shared-care (SC) programme to improve the quality of care (QOC) for DM and HT patients. The evaluation on the QOC is an essential part of the programme in order to inform future policy. The Family Medicine Unit (FMU) of the University of Hong Kong (HKU) has been appointed by the HA to carry out the evaluation of the QOC of the programme.
The Action Learning and Audit Spiral methodologies to measure whether the target standard of care intended by the SC programme is achieved. Each SC participating clinic and private medical practitioner (PMP) will be invited to complete a structured evaluation questionnaire. The data of all patients who have enrolled into the programme will be included in the evaluation on the process and outcomes of care. A hundred and thirty participants will be followed up by telephone to evaluate the effect of the programme in quality of life (QOL), patient enablement, and global rating of change in health condition at baseline and 6 months after enrolment. Data on the process of care will be retrieved from the HA medical records.
Main Outcome Measures: The primary outcomes are the proportion of participants who received the criterion process of care and achieved a HbA1c level <7.5%.
Data Analysis: Descriptive statistics on proportions of clinics or subjects meeting the quality of care criteria will be calculated. The outcomes of SC patients will be compared at 6, 12, 24, 36 and 48 months by paired sample t-test. The outcomes between SC patients and control group will be compared by independent sample t-test or Chi-square test.
Hypothesis: The QOC of the SC programme will be determined. Areas of deficiency and possible areas for quality enhancement will be identified. The results of this study will provide empirical evidence on whether the HA's SC programme can achieve equivalent QOC as the usual HA care for diabetes mellitus (DM) patients. The information will be used to guide service planning and policy decision making.
調査の概要
状態
条件
研究の種類
入学 (実際)
連絡先と場所
研究場所
-
-
Hksar
-
Hong Kong、Hksar、香港
- The University of Hong Kong
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
サンプリング方法
調査対象母集団
説明
Inclusion Criteria:
- Patients with diabetes mellitus who have received care at the specialist outpatient clinic (SOPC)for at least 2 years, stratified to be of low risk and have normal renal function as defined by the plasma creatinine level.
Exclusion Criteria:
- Patients will be excluded if they are stratified to be at high cardiovascular risk or are suffering end stage renal failure, on dialysis or after transplantation, or on insulin, or do not give consent to be transferred.
研究計画
研究はどのように設計されていますか？
デザインの詳細
コホートと介入
グループ/コホート |
|---|
|
DM subjects in Hong Kong
|
この研究は何を測定していますか？
主要な結果の測定
結果測定 |
時間枠 |
|---|---|
|
Change of the proportion of clinics that have satisfied each of the structure criteria.
時間枠：December, 2010; December, 2011; December, 2012; December, 2013; December, 2014
|
December, 2010; December, 2011; December, 2012; December, 2013; December, 2014
|
|
Change of the proportion of patients who have received with the SC criterion process of care.
時間枠：June, 2011; December, 2011; December, 2012; December, 2013; December, 2014
|
June, 2011; December, 2011; December, 2012; December, 2013; December, 2014
|
|
Change of the proportion of patients who have achieved a HbA1c <7.5%.
時間枠：June, 2011; December, 2011; December, 2012; December, 2013; December, 2014
|
June, 2011; December, 2011; December, 2012; December, 2013; December, 2014
|
二次結果の測定
結果測定 |
時間枠 |
|---|---|
|
Low-density lipoprotein (LDL)
時間枠：Baseline, 6, 12, 24, 36 and 48 months after enrollment.
|
Baseline, 6, 12, 24, 36 and 48 months after enrollment.
|
|
Blood pressure (BP)
時間枠：Baseline, 6, 12, 24, 36 and 48 months after enrollment.
|
Baseline, 6, 12, 24, 36 and 48 months after enrollment.
|
|
Body mass index (BMI)
時間枠：Baseline, 6, 12, 24, 36 and 48 months after enrollment.
|
Baseline, 6, 12, 24, 36 and 48 months after enrollment.
|
|
Cardiovascular complications
時間枠：Baseline, 6, 12, 24, 36 and 48 months after enrollment.
|
Baseline, 6, 12, 24, 36 and 48 months after enrollment.
|
|
Patient reported outcomes (PRO) measured by the change in Short Form-12 version 2 (SF-12v2) scores at 6 months.
時間枠：Baseline and 6 months after the first administration of questionnaire.
|
Baseline and 6 months after the first administration of questionnaire.
|
|
Patient reported outcomes (PRO) measured by the change in the Patient Enablement Instrument (PEI) scores at 6 months.
時間枠：Baseline and 6 months after the first administration of questionnaire.
|
Baseline and 6 months after the first administration of questionnaire.
|
|
Patient reported outcomes (PRO) measured by the change in the Global Rating Scale (GRS) at 6 months.
時間枠：Baseline and 6 months after the first administration of questionnaire.
|
Baseline and 6 months after the first administration of questionnaire.
|
|
Service utilization outcomes measured by General Outpatient Clinics (GOPC) attendance rates at baseline and 12, 24, 36 and 48 months after enrollment.
時間枠：Baseline, 12, 24, 36 and 48 months after enrollment
|
Baseline, 12, 24, 36 and 48 months after enrollment
|
|
Service utilization outcomes measured by specialist outpatient clinic (SOPC) attendance rates at baseline and 12, 24, 36 and 48 months after enrollment.
時間枠：Baseline, 12, 24, 36 and 48 months after enrollment
|
Baseline, 12, 24, 36 and 48 months after enrollment
|
|
Service utilization outcomes measured by accident & emergency (A&E) attendance rates at baseline and 12, 24, 36 and 48 months after enrollment.
時間枠：Baseline, 12, 24, 36 and 48 months after enrollment
|
Baseline, 12, 24, 36 and 48 months after enrollment
|
|
Service utilization outcomes measured by hospital attendance rates at baseline and 12, 24, 36 and 48 months after enrollment.
時間枠：Baseline, 12, 24, 36 and 48 months after enrollment
|
Baseline, 12, 24, 36 and 48 months after enrollment
|
協力者と研究者
研究記録日
主要日程の研究
研究開始
一次修了 (実際)
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。